Filtered By:
Management: Food and Drug Administration (FDA)
Procedure: CT Scan

This page shows you your search results in order of date.

Order by Relevance | Date

Total 3 results found since Jan 2013.

MRI for all: Cheap portable scanners aim to revolutionize medical imaging
.news-article__hero--featured .parallax__element{ object-position: 47% 50%; -o-object-position: 47% 50%; } The patient, a man in his 70s with a shock of silver hair, lies in the neuro intensive care unit (neuro ICU) at Yale New Haven Hospital. Looking at him, you’d never know that a few days earlier a tumor was removed from his pituitary gland. The operation didn’t leave a mark because, as is standard, surgeons reached the tumor through his nose. He chats cheerfully with a pair of research associates who have come to check his progress with a new and potentially revolutionary device they are testing. The cylind...
Source: Science of Aging Knowledge Environment - February 23, 2023 Category: Geriatrics Source Type: research

New ‐onset retroperitoneal fibrosis following COVID‐19 mRNA vaccination: Coincidental or vaccine‐induced phenomenon?
AbstractThe Pfizer-BioNTech mRNA vaccine is a US Food and Drug Administration-approved coronavirus disease 2019 (COVID-19) vaccine. Although it is reported to be safe and effective, immune dysregulation leading to autoimmunity has become an area of concern. Retroperitoneal fibrosis (RPF) is an immune-mediated fibroinflammatory disease characterized by the deposition of fibrous tissues, primarily around the abdominal aorta and iliac arteries. Herein, we report a case of RPF following Pfizer BioNTech COVID-19 mRNA vaccination. To the best of our knowledge, there have been no published reports on RPF after COVID-19 mRNA vacci...
Source: International Journal of Rheumatic Diseases - February 23, 2023 Category: Rheumatology Authors: Hirut Yadeta Ture, Na Ri Kim, Eon Jeong Nam Tags: CASE REPORT Source Type: research

Can Artificial Intelligence effectively and ethically detect COVID-19?
Is Artificial Intelligence (AI) a viable solution to the COVID-19 testing crisis? This has been a major question buzzing in the minds of healthcare leaders as they scramble to come up with solutions to the short-supply of the conventional tests. Some researchers believe that it ’s possible to develop a specialized method to detect specific markers of the virus via AI. However, COVID-19-detecting algorithms are based on data from only dozens or hundreds of patients, whereas a fully effective and functional algorithm requires thousands of patient scans. Recently written algorithms were developed using scans of infected C...
Source: radRounds - April 19, 2020 Category: Radiology Authors: Julie Morse Source Type: blogs